Evidence map›Paper›PMID 26535892›Full record

ArticlePloS one2015

SOX2 and SOX2-MYC Reprogramming Process of Fibroblasts to the Neural Stem Cells Compromised by Senescence.

Marta Winiecka-Klimek, Maciej Smolarz, Maciej P Walczak, Jolanta Zieba, Krystyna Hulas-Bigoszewska, Blazej Kmieciak, Sylwester Piaskowski, Piotr Rieske, Dawid P Grzela, Ewelina Stoczynska-Fidelus

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. The hope, hype and obstacles surrounding cell therapy.Journal of cellular and molecular medicine · 2024
    Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Direct cell-fate conversion of somatic cells: Toward regenerative medicine and industries.Proceedings of the Japan Academy. Series B, Physical and biological sciences · 2020
    Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Marta Winiecka-KlimekDepartment of Research and Development, Celther Polska, Lodz, Poland.
Maciej SmolarzDepartment of Research and Development, Celther Polska, Lodz, Poland.
Maciej P WalczakDepartment of Research and Development, Celther Polska, Lodz, Poland.
Jolanta ZiebaDepartment of Research and Development, Celther Polska, Lodz, Poland.
Krystyna Hulas-BigoszewskaDepartment of Research and Development, Celther Polska, Lodz, Poland.
Blazej KmieciakDepartment of Medical Law, Chair of Human Sciences, Medical University of Lodz, Lodz, Poland.
Sylwester PiaskowskiDepartment of Research and Development, Celther Polska, Lodz, Poland.
Piotr RieskeDepartment of Research and Development, Celther Polska, Lodz, Poland.
Dawid P GrzelaDepartment of Research and Development, Celther Polska, Lodz, Poland.
Ewelina Stoczynska-FidelusDepartment of Research and Development, Celther Polska, Lodz, Poland.
Medical University of Lodz · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tumorigenic potential of induced pluripotent stem cells (iPSCs) infiltrating population of induced neural stem cells (iNSCs) generated from iPSCs may limit their medical applications. To overcome such a difficulty, direct reprogramming of adult somatic cells into iNSCs was proposed. The aim of this study was the systematic comparison of induced neural cells (iNc) obtained with different methods-direct reprogramming of human adult fibroblasts with either SOX2 (SiNSc-like) or SOX2 and c-MYC (SMiNSc-like) and induced pluripotent stem cells differentiation to ebiNSc-in terms of gene expression profile, differentiation potential as well as proliferation properties. Immunocytochemistry and real-time PCR analyses were used to evaluate gene expression profile and differentiation potential of various iNc types. Bromodeoxyuridine (BrdU) incorporation and senescence-associated beta-galactosidase (SA-β-gal) assays were used to estimate proliferation potential. All three types of iNc were capable of neuronal differentiation; however, astrocytic differentiation was possible only in case of ebiNSc. Contrary to ebiNSc generation, the direct reprogramming was rarely a propitious process, despite 100% transduction efficiency. The potency of direct iNSCs-like cells generation was lower as compared to iNSCs obtained by iPSCs differentiation, and only slightly improved when c-MYC was added. Directly reprogrammed iNSCs-like cells were lacking the ability to differentiate into astrocytic cells and characterized by poor efficiency of neuronal cells formation. Such features indicated that these cells could not be fully reprogrammed, as confirmed mainly with senescence detection. Importantly, SiNSc-like and SMiNSc-like cells were unable to achieve the long-term survival and became senescent, which limits their possible therapeutic applicability. Our results suggest that iNSCs-like cells, generated in the direct reprogramming attempts, were either not fully reprogrammed or reprogrammed only into neuronal progenitors, mainly because of the inaccuracies of currently available protocols.

Indexed as

Cellular ReprogrammingCellular SenescenceCellular Reprogramming TechniquesFibroblastsHumansNeural Stem CellsProto-Oncogene Proteins c-mycSOXB1 Transcription FactorsTransduction, GeneticMYC protein, humanProto-Oncogene Proteins c-mycSOX2 protein, humanSOXB1 Transcription Factors

Identifiers

PMID26535892
PMCPMC4633175
OpenAlexW2222248410

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.